Cargando…
Jaw osteosarcoma models in mice: first description
BACKGROUND: Osteosarcoma (OS) is the most common cancer of bone. Jaw osteosarcoma (JOS) is rare and it differs from other OS in terms of the time of occurrence (two decades later) and better survival. The aim of our work was to develop and characterize specific mouse models of JOS. METHODS: Syngenic...
Autores principales: | Bertin, Hélios, Guilho, Romain, Brion, Régis, Amiaud, Jérôme, Battaglia, Séverine, Moreau, Anne, Brouchet-Gomez, Anne, Longis, Julie, Piot, Benoit, Heymann, Dominique, Corre, Pierre, Rédini, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391788/ https://www.ncbi.nlm.nih.gov/pubmed/30813941 http://dx.doi.org/10.1186/s12967-019-1807-5 |
Ejemplares similares
-
Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
por: Bertin, Hélios, et al.
Publicado: (2023) -
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015) -
LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021) -
ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021) -
Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
por: Odri, Guillaume, et al.
Publicado: (2014)